Literature DB >> 15544560

Recent advances in the medicinal chemistry of alpha-aminoboronic acids, amine-carboxyboranes and their derivatives.

Valery M Dembitsky1, Abed Al Aziz Quntar, Morris Srebnik.   

Abstract

This article describes recent developments in the synthesis and biological activity of alpha-aminoboronic acids, amine-carboxyboranes and their derivatives as potential therapeutic agents. alpha-Amino acid analogues are of considerable interest as inhibitors of enzymes involved in amino acid and peptide metabolism. In particular, alpha-amino alkylphosphonic acids and alpha-amino alkylboronic acids, in which the carboxyl group of amino acids is replaced by a phosphonic acid or boronic acid function, respectively, constitute a unique class of amino acid mimics from which a number of potent enzyme inhibitors have been synthesized. The inhibitory activity mainly stems from the fact that the tetrahedral phosphonic moiety or the tetrahedral adduct of electrophilic boronic acid is a good mimic of the putative tetrahedral transition state or intermediate encountered in the enzymatic hydrolysis or formation of peptides. Since the peptide hydrolysis and formation invariably involves the tetrahedral high energy species in the course of the reaction, these amino acid mimics serve as a general key element for inhibitors of a broad spectrum of proteases and peptide ligases. Serine protease inhibitors provide promising compounds having a P site binding moiety and a boronic acid chelating moiety. The compounds have been shown to have high inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544560     DOI: 10.2174/1389557043403125

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  9 in total

1.  Heats of Formation for the Boronic Acids R-B(OH)2 and Boroxines R3B3O3 (R=H, Li, HBe, H2B, H3C, H2N, HO, F, and Cl) Calculated at the G2, G3, and G4 Levels of Theory.

Authors:  Charles W Bock; Joseph D Larkin
Journal:  Comput Theor Chem       Date:  2012-04-15       Impact factor: 1.926

2.  Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders.

Authors:  Kay Ahn; Douglas S Johnson; Benjamin F Cravatt
Journal:  Expert Opin Drug Discov       Date:  2009-07       Impact factor: 6.098

3.  Thermodynamics of boroxine formation from the aliphatic boronic acid monomers R-B(OH)2 (R = H, H3C, H2N, HO, and F): a computational investigation.

Authors:  Krishna L Bhat; George D Markham; Joseph D Larkin; Charles W Bock
Journal:  J Phys Chem A       Date:  2011-06-08       Impact factor: 2.781

4.  A Comparison of the Structure and Bonding in the Aliphatic Boronic R-B(OH)2 and Borinic R-BH(OH) acids (R=H; NH2, OH, and F): A Computational Investigation.

Authors:  Niny Z Rao; Joseph D Larkin; Charles W Bock
Journal:  Struct Chem       Date:  2015-12-30       Impact factor: 1.887

5.  Synthesis of 1,2,3-triazol-1-yl-methaneboronic acids via click chemistry: an easy access to a new potential scaffold for protease inhibitors.

Authors:  Chiara Romagnoli; Emilia Caselli; Fabio Prati
Journal:  European J Org Chem       Date:  2015-02-01

6.  Toxicological investigation and antinociceptive property of potassium thiophene-3-trifluoroborate.

Authors:  Roberta A Oliveira; Lucielli Savegnago; Cristiano R Jesse; Paulo H Menezes; Gary A Molander; Cristina W Nogueira
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-03-27       Impact factor: 4.080

7.  Computational investigation of the oxidative deboronation of boroglycine, H2N-CH2-B(OH)2, Using H2O and H2O2.

Authors:  Joseph D Larkin; George D Markham; Matt Milkevitch; Bernard R Brooks; Charles W Bock
Journal:  J Phys Chem A       Date:  2009-10-15       Impact factor: 2.781

8.  On the Potential of Silicon as a Building Block for Life.

Authors:  Janusz Jurand Petkowski; William Bains; Sara Seager
Journal:  Life (Basel)       Date:  2020-06-10

9.  A solid-phase approach for the synthesis of α-aminoboronic acid peptides.

Authors:  Blake E Daniels; Craig E Stivala
Journal:  RSC Adv       Date:  2018-01-16       Impact factor: 4.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.